The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...

Philadelphia has lagged in biotech R&D jobs despite University of Pennsylvania scientists playing a leading role in ...

Is the biotech industry truly out of its slump? This week on "The Readout LOUD," a biotech year in review and a look ahead to ...

Trinity Biotech ( ($TRIB) ) just unveiled an update. On December 15, 2025, Trinity Biotech announced that it has secured regulatory clearances in ...

After a year marked by dramatic ups and downs, William Blair analysts say 2026 could carry forward the industry’s current ...

First, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) seeks daily investment results, before fees and expenses, of 300% of the performance of the aforementioned biotech index. Second, the ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody therapy designed to treat Alzheimer's disease. | Sanofi is back with its ...

Danaher Corporation DHR has been benefiting from strength in its Biotechnology segment. In the third quarter of 2025, the ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...